Researchers have achieved a clean reversal of Type 1 diabetes in mice by rebuilding their immune systems and restoring ...

Senescent fibroblasts are aging cells that no longer divide and protect against tumor development. Yet two decades have gone ...

The order of cancer-driving mutations—genetic changes—plays an important role in whether tumors in the intestine can develop, ...

Immorta Bio today announced the publication of a landmark preclinical study in the Journal of Translational Medicine demonstrating that its novel immunotherapy, SenoVax(TM), dramatically reduces ...

New research published in Nature Communications has linked a normal cellular process to an accumulation of DNA mutations in ...

Sickle cell disease is associated with chronic oxidative stress, hemolysis, inflammation, and progressive multi--organ injury, including significant cardiopulmonary complications. Mitochondrial ...

The companies plan to test the treatment's efficacy in preclinical models of squamous cell lung carcinoma early next year.

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...

Scientists at UCLA have developed an “off-the-shelf” cell-based immunotherapy that was able to track down and kill pancreatic ...

Companion animals often develop cancers similar to those found in humas. Dogs, in particular, have a vital role to play in the investigation of new cancer therapies. Increased funding and better ...